ArticlePreventive medicine reports2025
Characteristics and factors associated with initial antiretroviral medicine use among newly treated HIV/AIDS patients in Zhejiang Province, Eastern China: A cross-sectional study.
Article in Preventive medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hyperlipidemia and associated risk factors among people living with HIV on antiretroviral therapy: a retrospective cohort study from Eastern China.Preventive medicine reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study investigated characteristics and factors associated with initial antiretroviral medicine use among newly treated HIV/AIDS patients in Zhejiang Province, China, from 2019 to 2023. Methods: Data from the National Free Antiretroviral Therapy (ART) Database, covering the period from 2019 to 2023, were analyzed. ART regimens were classified as nationally free or medicare/self-paid. A multivariable logistic regression analysis was employed to identify factors influencing the initial ART regimen choice among those newly treated HIV/AIDS patients. Results: In total, 17,018 individuals with HIV who initiated ART were included in the analysis. The use of medicare/self-paid medicines increased from 2.8 % to 39.8 %. Individuals with HIV transmission through homosexual contact (aOR = 1.30, 95 % CI: 1.16-1.45), those who received a diagnosis through medical institutions (aOR = 1.59, 95 % CI: 1.41-1.80), those with World Health Organization clinical stage IV disease (aOR = 1.93, 95 % CI: 1.62-2.29), and patients with the baseline CD4 cell count <50 cells/μL were more likely to opt for medicare/self-paid medications. Conclusion: The proportion of medicare/self-paid medicine use among newly treated HIV/AIDS patients exhibited an increasing trend. Several factors, including the education level, transmission route, diagnosis approach, and WHO clinical stage, among others, were associated with the medication choice. Taken together, our results provide crucial evidence to aid policymakers in developing procurement plans and allocating medicines appropriately to better address the diverse needs of HIV/AIDS patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.